Workflow
动物疫苗产品
icon
Search documents
科前生物(688526.SH)发布上半年业绩,归母净利润2.2亿元,增长44.09%
智通财经网· 2025-08-25 10:08
Core Insights - The company reported a revenue of 487 million yuan for the first half of 2025, representing a year-on-year growth of 21.67% [1] - The net profit attributable to shareholders reached 220 million yuan, showing a year-on-year increase of 44.09% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 190 million yuan, reflecting a year-on-year growth of 43.12% [1] - The basic earnings per share stood at 0.47 yuan, indicating strong financial performance [1] - The increase in revenue is attributed to improved market conditions and rising sales volume [1]